NEW YORK – Johnson & Johnson (NYSE: JNJ) has cleared a key threshold of support for its proposed $6.5 billion […]
Johnson & Johnson (NYSE: JNJ) Clears Major Hurdle in $6.5 Billion Talc Settlement Read More »
Johnson & Johnson (NYSE: JNJ) reported better-than-expected earnings for the second quarter on Thursday and raised its full-year profit outlook.
Johnson & Johnson (NYSE: JNJ) Stock Jumps on Strong Q2 Earnings and Revenue Figures Read More »
LAVA Therapeutics N.V. (NASDAQ: LVTX) experienced a significant surge in its stock prices, rising by almost 36.84% after market hours
Johnson & Johnson (JNJ) Chooses LAVA Therapeutics (LVTX) for Cancer Study, Stock Surges Read More »
Copyright © 2024 abbonews.com
